To assess the safety of long-term use of cetirizine dry syrup in children with various type of cutaneous disease accompanied on pruritus.

Inclusion Criteria:

• Chronic urticaria
• Eczema & dermatitis group
• Atopic dermatitis
• Prurigo group: Acute prurigo, Prurigo subacuta, Chronic prurigo
• Pruritus cutaneous: Systemic pruritus cutaneous, Topical pruritus cutaneous
• Giving informed consent
• Children who have 2 grades or more pruritus score when assessed by the investigator or sub-investigator with the criteria for the diurnal or nocturnal pruritus score in the patient diary.
• Children with a pruritus severity of "2.Mild" or severer on the first day of the treatment period.

Exclusion criteria:

• have a history of drug hypersensitivity
• are pregnant, lactating or possibly pregnant female children.
• have asthma that requires the treatment with corticosteroid.
• cannot avoid the use of external steroid classified into "strong", "strongest" or "very strong".
• have pruritus only on face and head.
• have inappropriate complication of dermal disorder that may influence on the evaluation of the study drug.
• are undergoing specific desensitization therapy or immunomodulation therapy or phototherapy.